Neurotransmitters in biopolymers stimulate nerve regeneration

Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.

The technique would use a biodegradable polymer containing a chemical group that mimics the neurotransmitter acetylcholine to spur the growth of neurites, which are projections that form the connections among neurons and between neurons and other cells. The biomimetic polymers would then guide the growth of the regenerating nerve.

There is currently no treatment for recovering human nerve function after injury to the brain or spinal cord because central nervous system neurons have a very limited capability of self-repair and regeneration.

“Regeneration in the central nervous system requires neural activity, not just neuronal growth factors alone, so we thought a neurotransmitter might send the necessary signals,” said Yadong Wang, assistant professor in the Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, and principal investigator of the study. The research was supported by Georgia Tech, the National Science Foundation and the National Institute of Biomedical Imaging and Bioengineering (NIBIB).

Chemical neurotransmitters relay, amplify and modulate signals between a neuron and another cell. This new study shows that integrating neurotransmitters into biodegradable polymers results in a biomaterial that successfully promotes neurite growth, which is necessary for victims of central nervous system injury, stroke or certain neurodegenerative diseases to recover sensory, motor, cognitive or autonomic functions.

Wang and graduate student Christiane Gumera developed novel biodegradable polymers with a flexible backbone that allowed neurotransmitters to be easily added as a side chain. In its current form, the polymer would be implanted via surgery to repair damaged central nerves.

“One of our ultimate goals is to create a conduit for nerve regeneration that guides the neurons to regenerate, but gradually degrades as the neurons regenerate so that it won’t constrict the nerves permanently,” explained Wang.

For the experiments, the researchers tested polymers with different concentrations of the acetylcholine-mimicking groups. Acetylcholine was chosen because it is known to induce neurite outgrowth and promote the formation and strengthening of synapses, or connections between neurons. They isolated ganglia nervous tissue samples, placed them on the polymers and observed new neurites extend from the ganglia.

Since these neuron extensions must traverse a growth inhibiting material in the body, Wang and Gumera tested the ability of the biomaterial to enhance the extension of sprouted neurites. More specifically, they assessed whether the ganglia sprouted at least 20 neurites and then measured neurite length and neurite length distribution with an inverted phase contrast microscope.

“We found that adding 70 percent acetylcholine to the polymer induced regenerative responses similar to laminin, a benchmark material for nerve culture,” said Wang. Seventy percent acetylcholine also led to a neurite growth rate of up to 0.7 millimeters per day, or approximately half the thickness of a compact disc.

Laminin is a natural protein present in the nervous tissues, but it dissolves in water, making it difficult to incorporate into a conduit that needs to support nerves for months. A synthetic polymer with acetylcholine functional groups, on the other hand, can be designed to be insoluble in water, according to Wang.

Since functional restoration after nerve injury requires synapse formation, the researchers also searched for the presence of synaptic vesicle proteins on the newly formed neurites. With fluorescence imaging, they found that neurons cultured on these acetylcholine polymers expressed an established neuronal marker called synaptophysin.

To provide insights to new approaches in functional nerve regeneration, the researchers are currently investigating the mechanisms by which the neurons interact with these polymers. Since neurons that remain intact after severe injury have only a limited capacity to penetrate the scar tissue, these new findings in nerve regeneration could help compensate for the lost connections.

“This polymer and approach aren’t limited to nerve regeneration though, they can probably be used for other neurodegenerative disorders as well,” added Wang.

Source: Georgia Institute of Technology

Related stories:

Widely used iron nanoparticles exhibit toxic effects on neuronal cells
Researchers at UC San Diego have discovered that iron-containing nanoparticles being tested for use in several biomedical applications can be toxic to nerve cells and interfere with the formation of their signal-transmitting extensions.
Wiring the Brain at the Nanoscale
Nanowires in blood vessels may help monitor, stimulate neurons in the brain

Working with platinum nanowires 100 times thinner than a human hair--and using blood vessels as conduits to guide the wires--a team of U.S. and Japanese researchers has demonstrated a technique that may one day allow doctors to monitor individual brain cells and perhaps provide new treatments for neurological diseases such as Parkinson's.
Scientists develop a mouse model of sudden infant death syndrome
Sudden Infant Death Syndrome (SIDS) is a condition that unexpectedly and unexplainably takes the lives of seemingly healthy babies aged between a month and a year. Now researchers of the European Molecular Biology Laboratory in Monterotondo, Italy, have developed a mouse model of the so-called crib or cot death, which remains the leading cause of death during the first year of life in developed countries. The model, published in this week's issue of Science, reveals that an imbalance of the neuronal signal serotonin in the brainstem is sufficient to cause sudden death in mice.
Researchers link early stem cell mutation to autism
In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism. The study demonstrated that mice lacking the myocyte enhancer factor 2C (MEF2C) protein in neural stem cells had smaller brains, fewer nerve cells and showed behaviors similar to those seen in humans with a form of autism known as Rett Syndrome.
Migraine mutations reveal clues to biological basis of disorder
Fifteen percent to 20 percent of people worldwide suffer from migraines – excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder.
Tufts to develop morphing 'chemical robots'
Tufts University has received federal funding to develop chemical robots that will be able to squeeze into spaces as tiny as 1 centimeter, then morph into something 10 times larger, and ultimately biodegrade. The "chembots" could access urban environments, tunnels, caves and debris fields, and carry out other risky operations in complex environments.
Reprogramming Adult Stem Cells in the Brain
In recent years, stem cell researchers have become very adept at manipulating the fate of adult stem cells cultured in the lab. Now, researchers at the Salk Institute for Biological Studies achieved the same feat with adult neural stem cells still in place in the brain. They successfully coaxed mouse brain stem cells bound to join the neuronal network to differentiate into support cells instead.
Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience. The research, an important step toward developing new treatments for stroke, Alzheimer's, Parkinson's and other neurological conditions showed that mice afflicted by stroke showed tangible therapeutic improvement following transplantation of these cells. None of the mice formed tumors, which had been a major setback in prior attempts at stem cell transplantation.

News discussion:

Medicine & Health news